Because EPAS1 was densely and highly expressed in C3 AGT + Fibroblasts, and MYC was densely but poorly expressed in C3 AGT + Fibroblasts, whether inhibition or promotion of EPAS1 and MYC is beneficial to the treatment of cardiomyopathy requires further study. The gene discussed is MYC; the disease is cardiomyopathy.